XENETIC BIOSCIENCES

xenetic-biosciences-logo

Xenetic is a leading UK-based biopharmaceutical company providing leading-edge expertise in the development of a whole new generation of drugs, cancer therapies, and vaccines. Xenetic Biosciences is formerly known as Lipoxen. Working with some of the largest pharmaceutical organizations in the world, Xenetic provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology.

#SimilarOrganizations #People #Financial #Website #More

XENETIC BIOSCIENCES

Social Links:

Industry:
Biotechnology Clinical Trials Health Care Pharmaceutical

Founded:
2011-08-01

Address:
Framingham, Massachusetts, United States

Country:
United States

Website Url:
http://www.xeneticbio.com

Total Employee:
11+

Status:
Active

Contact:
44 20 3021 1500

Email Addresses:
[email protected]

Total Funding:
46.5 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Apache


Similar Organizations

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

alphamab-oncology-logo

Alphamab Oncology

Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

forma-therapeutics-logo

FORMA Therapeutics

FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.

immutep-logo

Immutep

Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.

recro-pharma-logo

Recro Pharma

Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.

Current Employees Featured

james-f-parslow_image

James F. Parslow
James F. Parslow Chief Financial Officer @ Xenetic Biosciences
Chief Financial Officer

gregory-gregoriadis_image

Gregory Gregoriadis
Gregory Gregoriadis Professor Emeritus @ Xenetic Biosciences
Professor Emeritus
1997-09-01

gregory-gregoriadis_image

Gregory Gregoriadis
Gregory Gregoriadis Founder, Senior member & Scientific Advisory Board @ Xenetic Biosciences
Founder, Senior member & Scientific Advisory Board
1997-09-01

not_available_image

M Scott Maguire
M Scott Maguire CEO @ Xenetic Biosciences
CEO

Founder


gregory-gregoriadis_image

Gregory Gregoriadis

Stock Details


Company's stock symbol is NASDAQ:XBIO

Investors List

baxter-international_image

Baxter International

Baxter International investment in Post-IPO Equity - Xenetic Biosciences

Official Site Inspections

http://www.xeneticbio.com Semrush global rank: 4.92 M Semrush visits lastest month: 1.76 K

  • Host name: ec2-174-129-30-187.compute-1.amazonaws.com
  • IP address: 174.129.30.187
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Xenetic Biosciences"

About :: Xenetic Biosciences, Inc. (XBIO)

Xenetic Biosciences, Inc. is a biopharmaceutical company focused on advancing innovative immune-oncology technologies addressing hard-to-treat cancers.See details»

Xenetic Biosciences - Crunchbase Company Profile & Funding

Contact Email [email protected] Phone Number 781-778-7720 Xenetic is a leading UK-based biopharmaceutical company providing leading-edge expertise in the development of a whole โ€ฆSee details»

Xenetic Biosciences, Inc. | LinkedIn

Xenetic Biosciences, Inc. (NASDAQ: XBIO) is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient โ€ฆSee details»

Xenetic Biosciences (XBIO) Company Profile & Description - Stock โ€ฆ

4 days ago Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers. The companyโ€™s proprietary DNase platform is โ€ฆSee details»

Xenetic Biosciences, Inc. Company Overview, Contact Details ...

Oct 12, 2022 Xeneticbio hired James F. Parslow as interim Chief Executive Officer on May 16th '24. FRAMINGHAM, MA / ACCESSWIRE / May 22, 2024 / Xenetic Biosciences, Inc. โ€ฆSee details»

Xenetic Biosciences - Overview, News & Similar companies

May 11, 2024 Xenetic Biosciences contact info: Phone number: (781) 778-7720 Website: www.xeneticbio.com What does Xenetic Biosciences do? Xenetic Biosciences, Inc., a clinical โ€ฆSee details»

Xenetic Biosciences Inc Company Profile - Overview - GlobalData

Website www.xeneticbio.com Telephone 1 781 7787720. No of Employees 4. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange XBIO (NASD) Revenue (2023) โ€ฆSee details»

Xenetic Biosciences - Craft

Oct 29, 2024 Xenetic Biosciences has 3 employees across 3 locations and $2.5 m in annual revenue in FY 2024. See insights on Xenetic Biosciences including office locations, โ€ฆSee details»

Contact :: Xenetic Biosciences, Inc. (XBIO)

We'd Love to Hear from You. Corporate Headquarters 945 Concord Street Framingham, MA 01701. Phone: 781-778-7720 [email protected]. Investor RelationsSee details»

Xenetic Biosciences, Inc. (XBIO)

May 14, 2025 Advancing Innovative Immune-Oncology Technologies We are a biopharmaceutical company focused on advancing proprietary technology platforms across โ€ฆSee details»

Press Releases - xeneticbio.com

For more information, please visit the Company's website at www.xeneticbio.com and connect on Twitter, LinkedIn, and Facebook. Forward-Looking Statements. This press release contains โ€ฆSee details»

Email Alerts :: Xenetic Biosciences, Inc. (XBIO)

We respect your privacy. We do not sell, rent, or loan any information to any third party. Any information you give us is held with the utmost care and security, and will be used only in ways โ€ฆSee details»

Investor Relations :: Xenetic Biosciences, Inc. (XBIO)

Transfer Agent Empire Stock Transfer, Inc. 1859 Whitney Mesa Drive Henderson, NV 89014 T: 702-818-5898See details»

Xenetic Biosciences, Inc. Reports Full Year 2024 Financial Results

For more information, please visit the Company's website at www.xeneticbio.com and connect on X, LinkedIn, and Facebook. Forward-Looking Statements This press release contains forward โ€ฆSee details»

Press Releases - xeneticbio.com

For more information, please visit the Company's website at www.xeneticbio.com and connect on X, LinkedIn, and Facebook. Forward-Looking Statements. This press release contains forward โ€ฆSee details»

Pipeline :: Xenetic Biosciences, Inc. (XBIO)

Product Pipeline. Innovative Oncology Pipeline Opportunity to Address Multiple Oncology IndicationsSee details»

Press Releases - ir.xeneticbio.com

Mar 26, 2025 Investigator initiated study with collaboration partner, PeriNess, to be conducted at the Tel-Aviv Sourasky Medical Center. FRAMINGHAM, MA / ACCESS Newswire / March 26, โ€ฆSee details»

Press Releases - ir.xeneticbio.com

Feb 27, 2025 For more information, please visit the Company's website at www.xeneticbio.com and connect on X, LinkedIn, and Facebook. Contact: JTC Team, LLC Jenene Thomas (908) โ€ฆSee details»

DNase I Oncology Platform :: Xenetic Biosciences, Inc. (XBIO)

Understanding the Role of NETs. NETs are weblike structures composed of extracellular chromatin coated with histones and other proteins. NETs are expelled by activated โ€ฆSee details»

Press Releases - ir.xeneticbio.com

A video webcast of the presentation will be accessible for viewing on-demand beginning on Monday, September 12 at 7:00 AM ET for those registered for the event and will be available โ€ฆSee details»

linkstock.net © 2022. All rights reserved